Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Noven Pharmaceuticals (NOVN) -- Ignore unavailable to you. Want to Upgrade?

To: Sr K who wrote (56)	11/16/1999 12:32:00 AM
From: Sr K	Respond to of 66

This is test2 which will get edited: June 30, 1999 December 31, 1998 (UNAUDITED) (AUDITED) -------- -------- <S> <C> <C> ASSETS Current Assets: Cash and cash equivalents $ 7,293 $ 5,573 Accounts receivable (less allowance for doubtful accounts of $168 in 1999 and $268 in 1998) 4,201 3,044 Due from Vivelle Ventures LLC 3,284 3,489 Inventories 2,934 2,733 Prepaid and other current assets 350 421 -------- -------- 18,062 15,260 Property, Plant and Equipment: Property, plant and equipment, at cost 20,887 20,376 Less: accumulated depreciation and amortization 5,544 4,859 -------- -------- 15,343 15,517 Other Assets: Investment in Vivelle Ventures LLC 6,878 7,500 Patent development costs, net 1,816 1,765 Deposits and other assets 421 114 -------- -------- 9,115 9,379 -------- -------- $ 42,520 $ 40,156 ======== ======== The Editing your message screen does not give you a choice to use fixed fonts.